151
Views
15
CrossRef citations to date
0
Altmetric
Original Articles

Formulation strategies for achieving high delivery efficiency of thymoquinone-containing Nigella sativa extract to the colon based on oral alginate microcapsules for treatment of inflammatory bowel disease

, , &
Pages 204-214 | Received 12 Jan 2019, Accepted 14 May 2019, Published online: 04 Jun 2019

References

  • Auriemma, G., et al., 2013. Prilling for the development of multi-particulate colon drug delivery systems: pectin vs. pectin–alginate beads. Carbohydrate polymers, 92(1), 367–373.
  • Bourgou, S., et al., 2010. Bioactivities of black cumin essential oil and its main terpenes from Tunisia. South African journal of botany, 76(2), 210–216.
  • Bourgou, S., et al., 2010. Thymoquinone prevents and ameliorates dextran sulfate sodium-induced colitis in mice. Digestive diseases and sciences, 57(9), 2296–2303.
  • Chourasia, M.K. and Jain, S.K., 2003. Pharmaceutical approaches to colon targeted drug delivery systems. Journal of pharmacy and pharmaceutical sciences, 6(1), 33–66.
  • Dahan, A., Amidon, G.L., and Zimmermann, E.M., 2010. Drug targeting strategies for the treatment of inflammatory bowel disease: a mechanistic update. Expert review of clinical immunology, 6(4), 543–550.
  • Dosh, R.H., et al., 2019. Long-term in vitro 3D hydrogel co-culture model of inflammatory bowel disease. Scientific reports, 9, 1812.
  • El-Sherbiny, I.M. and Smyth, H.D., 2011. Smart magnetically responsive hydrogel nanoparticles prepared by a novel aerosol-assisted method for biomedical and drug delivery applications. Journal of nanomaterials, 2011(2011), 1–13.
  • Hariyadi, D.M., et al., 2010. Diffusion loading and drug delivery characteristics of alginate gel microparticles produced by a novel impinging aerosols method. Journal of drug targeting, 18(10), 831–841.
  • Holkem, A.T., et al., 2016. Development and characterization of alginate microcapsules containing Bifidobacterium BB-12 produced by emulsification/internal gelation followed by freeze drying. LWT food science and technology, 71, 302–308.
  • Kaplan, G., 2015. The global burden of IBD: from 2015 to 2025. Nature reviews gastroenterology & hepatology, 12(12), 720–727.
  • Khan, T. and Kahn, A., 2017. Effect of Nigella sativa in experimentally induced inflammatory bowel disease in rats. International journal of pharmaceutics, 7(1), 109–115.
  • Kwok, K.K., Groves, M.J., and Burgess, D.J., 1991. Production of 5–15 microns diameter alginate-polylysine microcapsules by an air-atomization technique. Pharmaceutical research, 08(3), 341–344.
  • Lee, K.Y. and Mooney, D.J., 2012. Alginate: properties and biomedical applications. Progress in polymer science, 37 (1), 106–126.
  • Lim, L. and Wan, L., 1997. Propranolol hydrochloride binding in calcium alginate beads. Drug development and industrial pharmacy, 23(10), 973–980.
  • Loh, Q.L., Wong, Y.Y., and Choong, C., 2012. Combinatorial effect of different alginate compositions, polycations, and gelling ions on microcapsule properties. Colloid and polymer science, 290(7), 619–629.
  • Mansour, M.A., et al., 2002. Effects of thymoquinone on antioxidant enzyme activities, lipid peroxidation and DT-diaphorase in different tissues of mice: a possible mechanism of action. Cell biochemistry and function, 20(2), 143–151.
  • Melvik, J. E. and Dornish, M., 2004 Alginate as a carrier for cell immobilisation. In: V. Nedovic and R. Willaert, eds. Fundamentals of cell immobilisation biotechnology [Internet]. Dordrecht, Netherlands: Springer, 33–51. [cited 2017 May 1]. Focus on Biotechnology; vol. 8A. Available from: http://www.springer.com/us/book/9781402018879.
  • Mohammed, A.R., Coombes, A.G.A., and Perrie, Y., 2007. Amino acids as cryoprotectants for liposomal delivery systems. European journal of pharmaceutical sciences, 30 (5), 406–413.
  • Paarakh, P.M., 2010. Nigella Sativa Linn- A comprehensive review. Indian journal of natural products and resources, 1 (4), 409–429.
  • Samak, Y.O., El-Massik, M., and Coombes, A., 2017. A comparison of aerosolization and homogenization techniques for production of alginate microparticles for delivery of corticosteroids to the colon. Journal of pharmaceutical sciences, 106(1), 208–216.
  • Sanna, V., et al., 2015. Polymeric nanoparticles encapsulating white tea extract for nutraceutical application. Journal of agricultural and food chemistry, 63(7), 2026–2032.
  • Senuma, Y., et al., 2000. Alginate hydrogel microspheres and microcapsules prepared by spinning disk atomization. Biotechnology and bioengineering, 67(5), 616–622.
  • Sharma, O.P. and Bhat, T.K., 2009. DPPH antioxidant assay revisited. Food chemistry, 113(4), 1202–1205.
  • Shilpa, A., Agrawal, S.S., and Ray, A.R., 2003. Controlled delivery of drugs from alginate matrix. Journal of macromolecular science, part C, 43(2), 187–221.
  • Shukla, R.K. and Tiwari, A., 2012. Carbohydrate polymers: applications and recent advances in delivering drugs to the colon. Carbohydrate polymers, 88(2), 399–416.
  • Stanick, K. and Gille, L., 2010. Is thymoquinone an antioxidant? BMC pharmacology, 10(1), A9.
  • Suresh Kumar, T.V., Negi, P.S., and Udaya Sankar, K., 2010. Antibacterial activity of Nigella sativa L. seed extracts. British journal of pharmacology and toxicology, 1(2), 96–100.
  • Szekalska, M., et al., 2016. Alginate: current use and future perspectives in pharmaceutical and biomedical applications. International journal of polymer science, 2016, 1–17.
  • Tonnesen, H.H. and Karlsen, J., 2002. Alginate in drug delivery systems. Drug development and industrial pharmacy, 28(6), 621–630.
  • Van Assche, G., Vermeire, S., and Rutgeerts, P., 2009. Infliximab therapy for patients with inflammatory bowel disease: 10years on. European journal of pharmacology, 623(1), 17–25.
  • Woo, C.C., et al., 2013. Thymoquinone inhibits tumor growth and induces apoptosis in a breast cancer xenograft mouse model: the role of p38 MAPK and ROS. PLoS one, 8(10), e75356.
  • Yu, C.Y., et al., 2008. Sustained release of antineoplastic drugs from chitosan-reinforced alginate microparticle drug delivery systems. International journal of pharmaceutics, 357(1–2), 15–21.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.